Browsing by Subject

2023 GEIS Guidelines for gastrointestinal stromal tumors

Asencio, Jose Manuel; López-Guerrero, José Antonio; Rubió-Casadevall, Jordi; BAGUE, SILVIA; Serrano, Cesar; Martin-Broto, Javier (SAGE Publications, 2023)

A case report of long treatment with Itraconazole in a patient with chronic Chagas disease

Bosch Nicolau, Pau; Salvador Velez, Fernando M; Sánchez Montalvá, Adrián; Sulleiro Igual, Elena; Burgos Cibrian, Joaquin; Molina Romero, Israel (BMC, 2019-11-09)

A combination of molecular and clinical parameters provides a new strategy for high-grade serous ovarian cancer patient management

Bradbury Lobato, Melissa; Borràs, Eva; Vilar Sánchez, Marta Esther; Castellví Vives, Josep; Sánchez Iglesias, José Luis; Perez Benavente, Maria Asuncion; Gil Moreno, Antonio; Santamaria Margalef, Anna; Sabidó, Eduard (BMC, 2022-12-21)

A Comprehensive Biomarker Analysis of Microsatellite Unstable/Mismatch Repair Deficient Colorectal Cancer Cohort Treated with Immunotherapy

Elez Fernandez, Mª Elena; Mulet Margalef, Núria; Sanso Martinez, Miriam; Mancuso, Francesco Mattia; Ros Montañá, Fco. Javier; Argilés Martinez, Guillem; Martini, Giulia; Sanz Garcia, Enrique; Baraibar Argota, Iosune; Salva Ballabrera, Francesc; Noguerido Castro, Alba; Cuadra-Urteaga, Jose Luis; Fasani, Roberta; Garcia Rodriguez, Ariadna; Jiménez Catalan, Juan José; Aguilar, Susana; Hernandez Losa, Javier; Braña Garcia, Irene; Nuciforo, Paolo Giovanni; Dienstmann, Rodrigo; Tabernero Caturla, Josep; Salazar, Ramón; Vivancos Prellezo, Ana; Landolfi, Stefania; Comas Navarro, Raquel; Ruiz Pace, Fiorella (MDPI, 2022-12-21)

A DNA damage repair gene-associated signature predicts responses of patients with advanced soft-tissue sarcoma to treatment with trabectedin

Moura, David; Pena-Chilet, Maria; Cordero Varela, Juan Antonio; Alvarez-Alegret, Ramiro; Agra-Pujol, Carolina; Izquierdo, Francisco; Romagosa Pérez-Portabell, Cleofé; Valverde Morales, Claudia Maria (Wiley, 2021-12)

A Growth Modulation Index-Based GEISTRA Score as a New Prognostic Tool for Trabectedin Efficacy in Patients with Advanced Soft Tissue Sarcomas: A Spanish Group for Sarcoma Research (GEIS) Retrospective Study

Martínez-Trufero, Javier; De Sande-González, Luis Miguel; Luna, Pablo; Álvarez, Rosa; Valverde Morales, Claudia Maria; Martin-Broto, Javier; Marquina, Gloria (MDPI, 2021-02-14)

A large case series of travel-related Mansonella perstans (vector-borne filarial nematode): a TropNet study in Europe

Tamarozzi, Francesca; Rodari, Paola; Salas-Coronas, Joaquin; Bottieau, Emmanuel; Salvador Velez, Fernando M; Soriano-Pérez, Manuel Jesús; Treviño Maruri, Begoña (Oxford University Press, 2022-10)

A multi-stakeholder multicriteria decision analysis for the reimbursement of orphan drugs (FinMHU-MCDA study)

de Andrés‑Nogales, F.; Cruz, Encarnación; Calleja‐Hernández, Miguel Ángel; Delgado-Sanchez, Olga; Gorgas Torner, Maria Queralt; Espín Balbino, Jaime (BMC, 2021-04-26)

A multicenter, dose-finding, phase 1b study of imatinib in combination with alpelisib as third-line treatment in patients with advanced gastrointestinal stromal tumor

Pantaleo, Maria Abbondanza; Heinrich, Michael C.; Italiano, Antoine; Valverde Morales, Claudia Maria; Schöfski, Patrick; Grignani, Giovanni (BMC, 2022-05-06)

A Nephrologist Perspective on Obesity: From Kidney Injury to Clinical Management

García-Carro, Clara; Vergara Arana, Ander; Bermejo Garcia, Sheila; Azancot Rivero, M Antonieta; Sellarés Roig, Joana; Soler Romeo, Maria Jose (Frontiers Media, 2021-04)

A new BiofilmChip device for testing biofilm formation and antibiotic susceptibility

Blanco-Cabra, Núria; López-Martínez, Maria José; Arévalo-Jaimes, Betsy Verónica; Martin Gomez, M Teresa; Samitier, Josep; Torrents, Eduard (Nature Research, 2021-08-03)

A Phase 1 Drug-Drug Interaction Study Between Brigatinib and the CYP3A Substrate Midazolam in Patients With ALK-Positive or ROS1-Positive Solid Tumors

Hanley, Michael J; D’Arcangelo, Manolo; Felip Font, Enriqueta; Garrido, Pilar; Zhu, Jiaxi; Ye, Meng (Wiley, 2023-05)

A Phase 2 Randomized Controlled Trial of the Efficacy and Safety of Cannabidivarin as Add-on Therapy in Participants with Inadequately Controlled Focal Seizures

Brodie, Martin; Czapinski, Piotr; Pazdera, Ladislav; Sander, Josemir; Toledo Argany, Manuel; Napoles, Mariana (Mary Ann Liebert, 2021-12)

A Phase I Study Investigating AZD8186, a Potent and Selective Inhibitor of PI3Kβ/δ, in Patients with Advanced Solid Tumors

Choudhury, Atish D.; Higano, Celestia; Cook, Natalie; Rathkopf, Dana E.; Wisinski, Kari; Martín Liberal, Juan Jesús; de Bono, Johann S (American Association for Cancer Research, 2022-06-01)

A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patients with Advanced Adenoid Cystic Carcinoma and Other Tumors

Hanna, Glenn; Stathis, Anastasios; López Miranda, Elena ; Racca Bussano, Fabricio; Quon, Doris; Leyvraz, Serge; GARRALDA, Elena (American Association for Cancer Research, 2023-09-14)

A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 study

Español-Rego, Marta; Fernández‑Martos, Carlos; Elez, Elena; Foguet Coll, Carles; Pedrosa Eguílaz, Leire; Rodríguez, Nuria (Springer, 2023-04)

A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer

Jones, Robert; Plummer, Ruth; Moreno, Victor; Carter, Louise; Roda, Desamparados; Garralda Cabanas, Elena (American Association for Cancer Research, 2023-01-17)

A phase Ib/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer

Nadal, Ernest; Saleh, Mansoor; Patel, Sandip Pravin; Antonia, Scott; Ponce Aix, Santiago; Ochoa de Olza, Maria (BMC, 2023-07-28)

A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF V600E-Mutant KRAS Wild-Type Metastatic Colorectal Cancer

Van Cutsem, Eric; GARRALDA, Elena; Tai, David; de Braud, Filippo Guglielmo Maria; Geva, Ravit; Elez, Elena ; Tabernero, Josep (Oxford University Press, 2023-03)

A Phase II Trial of Prexasertib (LY2606368) in Patients With Extensive-Stage Small-Cell Lung Cancer

Byers, Lauren Averett; Navarro Mendivil, Alejandro; Schaefer, Eric; Johnson, Melissa L.; Özgüroglu, Mustafa; Han, Ji-Youn (Elsevier, 2021-11)

Scientia. Dipòsit d'Informació Digital del Departament de Salut